Home
Conditions
Breast Neoplasms

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

627 public trials 223 recruiting studies

Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Recruiting

An Open-label Prospective Study to Evaluate the Efficacy and Safety of Pegfilgrastim in Triple-Negative Breast Cancer Patients Receiving AC Regimen Following Paclitaxel and Carboplatin as Neoadjuvant Therapy

NCT07525869

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Severance Hospital, Yonsei University Health System Seoul, Seodaemun-gu, South Korea

Gangnam Severance Hospital, Yonsei University Health System Seoul, South Korea

View Trial Details

Recruiting

High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer

NCT06492759

Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +6 more
Locations: Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Recruiting

The PREDICT Registry:

NCT03448926

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +14 more
Locations: Arizona Center for Cancer Care Scottsdale, Arizona, United States

University of California San Diego La Jolla, California, United States

Sutter Health San Mateo, California, United States

University of Colorado Anschutz Medical Campus Aurora, Colorado, United States

View all 30 locations

View Trial Details

Recruiting

A Phase III Study of JSKN016 Versus Treatment of Physician's Choice in Patients With Triple-Negative Breast Cancer Who Have Failed Standard of Care

NCT07533123

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

FUSCC Refractory TNBC Platform Study (FUTURE2.0)

NCT05749588

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Fudan University Shanghai Cancer Center Shanghai, China

View Trial Details

Recruiting

Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

NCT00477100

Conditions: Breast Diseases, Breast Neoplasms, Inflammatory Breast Carcinoma, +8 more
Locations: Banner - MD Anderson Cancer Center Gilbert, Arizona, United States

Scripps - MD Anderson Cancer Center La Jolla, California, United States

Banner - MD Anderson Cancer Center - Northern Colorado Greeley, Colorado, United States

Baptist - MD Anderson Cancer Center Jacksonville, Florida, United States

View Trial Details

Recruiting

Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors

NCT07523529

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Unresectable, +50 more
Locations: Peking University Shenzhen Hospital Shenzhen, Guangdong, China

View Trial Details

Recruiting

A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha

NCT06547840

Conditions: Advanced Endometrial Cancer, Advanced Ovarian Cancer, Breast Diseases, +20 more
Locations: Bristol Haematology and Oncology Centre Bristol, United Kingdom

Edinburgh Cancer Research Centre Edinburgh, United Kingdom

Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom

Cambridge University - Addenbrooke's Hospital London, United Kingdom

View Trial Details

Recruiting

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

NCT06451497

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +58 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

NEXT Oncology Austin, TX 78758, Texas, United States

NEXT Oncology San Antonio, Texas, United States

View Trial Details

Recruiting

Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer

NCT06365788

Conditions: Breast Diseases, Breast Neoplasms, Bulbo-Spinal Atrophy, X-Linked, +16 more
Locations: ZAS Augustinus Antwerp, Belgium

Antwerp University Hospital Antwerp, Belgium

University Hospital Brussels Brussels, Belgium

Ghent University Hospital Ghent, Belgium

View Trial Details

Breast Neoplasms

Breast Neoplasms trial results

Related conditions